Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEGeneral Updates▲ PositiveExpansion12 Oct 2026

Hatsun Agro Product Limited

General Updates

Hatsun Agro Product Limited expects revenue to rise as much as 50% over the next two financial years, supported by a wider milk procurement network and expansion beyond its southern Indian stronghold.

Read more →📎 1 attachment
NSEPress Release (Revised)▲ PositiveOrder Win12 Oct 2026

Aequs Limited

Press Release (Revised)

Aequs Limited has signed long-term supply agreements with Safran for aerospace applications, strengthening their collaboration and highlighting Safran's commitment to working with trusted industrial partners.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A12 Oct 2026

Tavexia Lifecare Ltd

Announcement

Tavexia Lifecare Ltd has announced a strategic expansion and acquisition of a 60% controlling stake in Meyonex Pharmaceuticals for ₹67.19 Crore. The company is expanding into high-margin verticals, including APIs, finished dosage forms, CDMO, and nutraceuticals.

Read more →📎 1 attachment
NSEPress Release▲ PositiveProduct Launch12 Oct 2026

Crompton Greaves Consumer Electricals Limited

Press Release

Crompton Greaves Consumer Electricals Limited has launched the InstaNourish Pro Multi-Purpose Kettle, a compact appliance that enables searing, steaming, and boiling in one unit, catering to consumers' evolving needs for convenient and versatile cooking solutions.

Read more →📎 1 attachment
BSECompany Update▲ PositiveProduct Launch12 Oct 2026

Crompton Greaves Consumer Electricals Ltd

Press Release

Crompton Greaves Consumer Electricals Ltd has launched the InstaNourish Pro Multi-Purpose Kettle, a compact appliance that enables searing, steaming, and boiling in one device, catering to the needs of consumers with smaller kitchens and limited access to cooking appliances.

Read more →📎 1 attachment
BSECompany Update▲ PositiveProduct Launch12 Oct 2026

Zydus Lifesciences Ltd

Zydus Therapeutics Presents New Post Hoc Analysis of Phase 3 EPICS-III Trial at ACG 2026 Showing Greater Biochemical Response With Investigational Saroglitazar Compared to Placebo Across Geographic Subgroups in PBC.

Zydus Lifesciences Ltd announced that its subsidiary Zydus Therapeutics presented new post hoc analysis of Phase 3 EPICS-III trial at ACG 2026, showing greater biochemical response with investigational Saroglitazar compared to placebo across geographic subgroups in PBC.

Read more →📎 1 attachment
NSEPress Release▲ PositiveProduct Launch12 Oct 2026

Zydus Lifesciences Limited

Press Release

Zydus Lifesciences Limited has announced a press release regarding a new post hoc analysis of the Phase 3 EPICS-III trial at ACG 2026, showing greater biochemical response with investigational saroglitazar compared to placebo across geographic subgroups in PBC.

Read more →📎 1 attachment
BSECompany Update▲ PositiveM&A12 Oct 2026

Lords Mark Industries Ltd

Acquisition Intimation

Lords Mark Industries Ltd has completed the acquisition of Radio Electric Private Limited, the maker of the 'Radiotone' brand, as part of its strategic expansion into specialised electrical manufacturing and engineering.

Read more →📎 1 attachment
← PreviousPage 312 of 948Next →